Open access offers authors a number of benefits, including:
- Increased citation and usage
- Greater public engagement
- Faster impact
- Wider collaboration
- Compliance with funder mandates
- Increased interdisciplinary conversation
Creative Commons License
Articles are published under a CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license is preferred by many research funding bodies, and allows for maximum dissemination and re-use of open access materials. Alternative Creative Commons licenses are available on request: please contact the editorial office on acceptance of your article to discuss these options.
Under Creative Commons, authors retain copyright of their work. Learn more about Creative Commons licenses and the license options available in npj Vaccines.
Publishing with the journal offers authors a number of benefits, including:
Part of the Nature Partner Journals series, the journal is published by Springer Nature in partnership with the Sealy Center for Vaccine Development (SCVD). All Nature Partner Journals titles have strong editorial values and adhere to a modified set of Nature editorial standards under the leadership of Nature Editor-in-Chief, Sir Philip Campbell.
Ease of submission
Manuscripts submitted to npj Vaccines do not need to adhere to our formatting requirements at the point of initial submission; formatting requirements only apply at the time of acceptance.
Comprehensive and rigorous peer review
Manuscripts are evaluated by experienced editors and reviewers who are authorities in your field.
Rapid turnaround times
An average time to first decision within 26 days; the final version of a manuscript is published online within 25 days of acceptance.
Global reach and discoverability
Enhanced browsing and searching on nature.com means that articles are promoted, marketed and presented alongside other Nature Research content. Article level metrics showcase your personal research impact in academia and beyond.
Professional written Editorial Summaries
Professionally written Editorial Summaries accompany each original research article, opening up your research to the scientific community and succinctly communicating why your article is important.
Articles published in npj Vaccines will be included in monthly article e-alerts and regular email updates. A featured article is highlighted on the journal homepage each month, and may be selected to appear on the nature.com portal for partner publishing.
Articles published in npj Vaccines may be promoted by press release to the general or scientific press, utilizing Nature Research’s extensive international media database.
Abstracting and indexing
npj Vaccines is listed in the Directory of Open Access Journals (DOAJ), and is also covered in Web of Science (SCIE). The journal has also applied for inclusion within PubMed Central. Pending review and acceptance, all past published articles will automatically be indexed retrospectively. Authors with NIH/HHMI funding are able and encouraged to self-archive, which includes uploading manuscripts to PubMed Central before the journal is officially accepted.